Document is current
Any future updates will be listed below
-
Authors
Jewell, Sharon
Hobson, Stephen
Brewer, Grant
Rogers, Michelle
Hartings, Jed A.
Foreman, Brandon
Lavrador, José-Pedro
Sole, Michael
Pahl, Clemens
Boutelle, Martyn G.
Strong, Anthony J. https://orcid.org/0000-0003-2432-5945
-
Funding
Funding for this research was provided by:
Wellcome Trust (HICF-0510-080)
Office of the Under Secretary of Defense (W81XWH-16-2-0020)
Medical Research Council, UK (MR/R00112X/1)
- License Information
-
More Information
Article History
Received: 16 September 2020
Accepted: 4 March 2021
First Online: 26 July 2021
Declarations
:
: BF reports personal fees from UCB Pharma Inc., personal fees from Minnetronix, Inc., grants from the National Institutes of Health National Institute of Neurological Disorders and Stroke, grants from National Science Foundation, and grants from Department of Defense, all outside the submitted work. MGB reports grants from the Wellcome Trust and grants from Medical Research Council (UK) during the conduct of the study. In addition, MGB, with AJS and SJ, has a patent (WO/2019/150136) pending. GB reports grants from the Wellcome Trust during the conduct of the study. JAH reports grants from the US Office of the Assistant Secretary of Defense for Health Affairs through the Defense Medical Research and Development Program under award No. W81XWH-16-2-0020 during the conduct of the study. AJS reports a grant from the Health Innovation Challenge Fund of the Wellcome Trust and UK Department of Health and a grant from HeadFirst during the conduct of the study. CP, J-PL, MR, SH, and MS have nothing to disclose.
: This study was approved by the KCH Research Ethics Committee (Cambridgeshire South; 05/MRE05/7) and the UC Institutional Review Board (2016-8153).
